In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. By Rebecca Robbins With a sticker price ...

Kwon is a Ph.D. student in health policy at Harvard University. Stuart is professor and chair in the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health. It is human ...

The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request "unsupported by the scientific ...

Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting a potential link between its use during pregnancy and the development of ...

Patients with psoriatic arthritis (PsA) treated with biologics had lower rates of cardiovascular events and all-cause and cardiovascular mortality but a higher risk for infection-related admissions ...

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy to ...

The health secretary doubled down on his assertion that the over-the-counter pain reliever is problematic, noting, "We’re doing the studies to make the proof.” His claims are resonating with ...

With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the treatment of rheumatoid arthritis. London-based Elevara was founded by ...

Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during pregnancy, after President Donald Trump linked ...

Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes to the product’s safety label to reflect research about a possible ...